ProtoPulse · Protocoale terapeutice CNAS
Date actualizate 19.10.2026 22:37 · tipărit din ProtoPulse
Date actualizate 19.10.2026 22:37 · tipărit din ProtoPulse
FACTOR VIII DE COAGULARE
Substanță activă (DCI) · ATC B02BD02 · 27 produse autorizate în România
1
Protocoale în care se regăsește
Ca medicament al protocolului (în titlu) sau doar menționat în text
| Cod | Protocol | Stare | Rol | Sublistă | MF |
|---|---|---|---|---|---|
| BD01D | HEMOFILIA A si B si BOALA VON WILLEBRAND | În vigoare | menționat în text | C2-P6.1 | NU |
2
Produse comerciale autorizate (ANMDM)
Nomenclatorul medicamentelor de uz uman, actualizat zilnic
| Denumire comercială | Formă | Concentrație | Deținător | ATC | Rx |
|---|---|---|---|---|---|
| BERIATE 1000 UI | PULB.+SOLV. PT. SOL. INJ./PERF. | 1000UI | CSL BEHRING GMBH - GERMANIA | B02BD02 | PR |
| BERIATE 2000 UI | PULB.+SOLV. PT. SOL. INJ./PERF. | 2000UI | CSL BEHRING GMBH - GERMANIA | B02BD02 | PR |
| BERIATE 250 UI | PULB.+SOLV. PT. SOL. INJ./PERF. | 250UI | CSL BEHRING GMBH - GERMANIA | B02BD02 | PR |
| BERIATE 500 UI | PULB.+SOLV. PT. SOL. INJ./PERF. | 500UI | CSL BEHRING GMBH - GERMANIA | B02BD02 | PR |
| EMOCLOT 500 UI | PULB.+SOLV. SOL. PERF. | 500 UI | KEDRION S.P.A. - ITALIA | B02BD02 | PR |
| FANHDI 1000 UI | PULB.+SOLV. PT. SOL. INJ. | 1000UI | INSTITUTO GRIFOLS S.A. - SPANIA | B02BD02 | PR |
| FANHDI 250 UI | PULB.+SOLV. PT. SOL. INJ. | 250UI | INSTITUTO GRIFOLS S.A. - SPANIA | B02BD02 | PR |
| FANHDI 500 UI | PULB.+SOLV. PT. SOL. INJ. | 500UI | INSTITUTO GRIFOLS S.A. - SPANIA | B02BD02 | PR |
| HAEMATE P 1000UI FVIII/2400 UI FVW | PULB.+SOLV. PT. SOL. INJ. SAU PERF. | 1000UIFVIII/2400UIFVW | CSL BEHRING GMBH - GERMANIA | B02BD06 | PRF |
| HAEMATE P 250UI FVIII/600 UI FVW | PULB.+SOLV. PT. SOL. INJ. SAU PERF. | 250UIFVIII/600UIFVW | CSL BEHRING GMBH - GERMANIA | B02BD06 | PRF |
| HAEMATE P 500UI FVIII/1200 UI FVW | PULB.+SOLV. PT. SOL. INJ. SAU PERF. | 500UIFVIII/1200UIFVW | CSL BEHRING GMBH - GERMANIA | B02BD06 | PRF |
| HAEMOCTIN SDH 1000 | PULB.+SOLV. PT. SOL. INJ. | 200UI/ml | BIOTEST PHARMA GMBH - GERMANIA | B02BD02 | PR |
| HAEMOCTIN SDH 250 | PULB.+SOLV. PT. SOL. INJ. | 100UI/ml | BIOTEST PHARMA GMBH - GERMANIA | B02BD02 | PR |
| HAEMOCTIN SDH 500 | PULB.+SOLV. PT. SOL. INJ. | 100UI/ml | BIOTEST PHARMA GMBH - GERMANIA | B02BD02 | PR |
| IMMUNATE 1000 UI FVIII/750 UI FVW | PULB.+SOLV. PT. SOL. INJ. | 1000 UI /750 UI | BAXALTA INNOVATIONS GMBH - AUSTRIA | B02BD06 | PR |
| IMMUNATE 250 UI FVIII/190 UI FVW | PULB.+SOLV. PT. SOL. INJ. | 250 UI /190 UI | BAXALTA INNOVATIONS GMBH - AUSTRIA | B02BD06 | PR |
| IMMUNATE 500 UI FVIII/375 UI FVW | PULB.+SOLV. PT. SOL. INJ. | 500 UI /375 UI | BAXALTA INNOVATIONS GMBH - AUSTRIA | B02BD06 | PR |
| NUWIQ 1000UI | PULB.+SOLV. PT. SOL. INJ. | 1000 UI | OCTAPHARMA AB - SUEDIA | B02BD02 | PR |
| NUWIQ 2000UI | PULB.+SOLV. PT. SOL. INJ. | 2000 UI | OCTAPHARMA AB - SUEDIA | B02BD02 | PR |
| NUWIQ 250UI | PULB.+SOLV. PT. SOL. INJ. | 250 UI | OCTAPHARMA AB - SUEDIA | B02BD02 | PR |
| NUWIQ 500UI | PULB.+SOLV. PT. SOL. INJ. | 500 UI | OCTAPHARMA AB - SUEDIA | B02BD02 | PR |
| OCTANATE 100 UI/ml | PULB.+SOLV. PT. SOL. INJ. | 100UI/ml | OCTAPHARMA (IP) SPRL - BELGIA | B02BD02 | PR |
| OCTANATE 50 UI/ml | PULB.+SOLV. PT. SOL. INJ. | 50UI/ml | OCTAPHARMA (IP) SPRL - BELGIA | B02BD02 | PR |
| OCTANATE LV 100 UI/ml | PULB.+SOLV. PT. SOL. INJ. | 100UI/ml | OCTAPHARMA (IP) SPRL - BELGIA | B02BD02 | PR |
| OCTANATE LV 200 UI/ml | PULB.+SOLV. PT. SOL. INJ. | 200UI/ml | OCTAPHARMA (IP) SPRL - BELGIA | B02BD02 | PR |
| WILATE 1000 1000 UI FVW/1000 UI FVIII | PULB.+SOLV. PT. SOL. INJ. | 1000 UI FVW/1000 UI FVIII | OCTAPHARMA (IP) SPRL - BELGIA | B02BD06 | PR |
| WILATE 500 500 UI FVW/500 UI FVIII | PULB.+SOLV. PT. SOL. INJ. | 500 UI FVW/500 UI FVIII | OCTAPHARMA (IP) SPRL - BELGIA | B02BD06 | PR |